About Us

Company Profile

Pharmova is born out of a combination of ‘Pharma’ and ‘Nova’ (New) and Jubilant Pharmova Limited will continue to focus on offering products and services with, excellence in research and manufacturing, catering to the unmet health needs at an affordable price.

It is an integrated global pharmaceuticals company having three business segments  Pharmaceuticals, Contract Research and Development Services and Proprietary Novel Drugs.

 

Pharmaceuticals business through Jubilant Pharma Limited is engaged in manufacturing and supply of Radiopharmaceuticals with a network of 48 Radiopharmacies in the US, Allergy Therapy Products, Contract Manufacturing of Sterile Injectables and Non-sterile products, Active Pharmaceutical Ingredients and Solid Dosage Formulations through six USFDA approved manufacturing facilities in the US, Canada and India.

 

Contract Research and Development Services business represented by Jubilant Biosys Limited provides innovation and collaborative research to global pharmaceutical innovators through two world-class research centers in Bengaluru and Noida in India.

 

Proprietary Novel Drugs business through Jubilant Therapeutics Inc. is an innovative patient-centric biopharmaceutical company developing breakthrough therapies in the area of oncology and auto-immune disorders.

Business Units

  • Pharmaceuticals

    Jubilant Pharma Limited is engaged in manufacturing and supply of Radiopharmaceuticals with a network of 48 Radiopharmacies in the US, Allergy…

  • Contract Research and Development Services

    Jubilant Biosys Limited provides innovation and collaborative research to global pharmaceutical innovators through…

  • Proprietary Novel Drugs

    Jubilant Therapeutics Inc. is an innovative patient-centric biopharmaceutical company developing breakthrough therapies in the area of oncology and auto-immune disorders…

Jubilant Pharmova Limited has a team of around 5,800 multicultural people across the globe and is committed to delivering value to its customers. The Company is well recognized as a ‘Partner of Choice’ by leading pharmaceuticals worldwide.